AdipoGen Life Sciences

MTEP

CHF 100.00
In stock
AG-CR1-0022-M0055 mgCHF 100.00
AG-CR1-0022-M02525 mgCHF 400.00
More Information
Product Details
Synonyms 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine
Product Type Chemical
Properties
Formula

C11H8N2S

MW 200.3
CAS 329205-68-7
Purity Chemicals ≥98% (NMR)
Appearance Light yellow solid.
Solubility Soluble in DMSO, 100% ethanol or methanol.
Identity Determined by 1H-NMR.
InChi Key NRBNGHCYDWUVLC-UHFFFAOYSA-N
Smiles CC1=NC(=CS1)C#CC1=CC=CN=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage +4°C
Handling Advice Protect from light.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description
  • Potent and selective antagonist for mGluR5 [1, 2]. 
  • 5-fold higher anxiolytic activity than MPEP [3]. 
  • Antidepressant [4]. 
  • Neuroprotective [5]. 
  • Produces antiparkinsonian-like effects in rats [6]. 
Product References
  1. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity: J. Med. Chem. 46 204 (2003)
  2. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling: A. Klodzinska, et al.; Neuropharmacology 47, 342 (2004) 
  3. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP: P.M. Lea IV & A.I. Faden; CNS Drug Rev. 12, 149 (2006) 
  4. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist: A. Palucha, et al.; Pharmacol. Biochem. Behav. 81, 901 (2005) 
  5. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors: P.M.t. Lea, et al.; Br. J. Pharmacol. 145, 527 (2005) 
  6. MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats: K. Ossowska, et al.; Neuropharmacology 49, 447 (2005) 
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.